Search research articles
Contact Us
Filters
Showing results (141-150 of 182) with videos related to
Page
of 19
Sort By:
Medicina Clinica
|
September 25, 1981
[Comparative biochemical study of serum and residual peritoneal fluid in periodic peritoneal maintenance dialysis (author's transl)]
R Selgas Gutiérrez, D Lorenzo Aguiar, M Rivero Sánchez, et al.
Contributions to Nephrology
|
January 1, 1987
Peritoneal membrane failure as a determinant of the CAPD future. An epidemiological, functional and pathological study
E Huarte-Loza, R Selgas, A R Carmona, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia
|
October 30, 2008
Apoptosis: from advances in PD to therapeutic targets in DM
B Santamaría, A B Sanz, A C Ucero, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia
|
August 5, 2000
[Methods to assess the ex vivo growth capacity of mesothelial cells obtained directly from peritoneal effluent]
M A Castro, C Díaz, M A Bajo, et al.
Journal of Nephrology
|
August 17, 2001
Vascular endothelial growth factor (VEGF) levels in peritoneal dialysis effluent
R Selgas, G del Peso, M A Bajo, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis
|
January 1, 1993
Peritoneal resting is beneficial in peritoneal hyperpermeability and ultrafiltration failure
F de Alvaro, M J Castro, F Dapena, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia
|
January 26, 2010
[Ten-year experience in intensive theoretical-practical course of ongoing training in peritoneal dialysis]
C Hevia Ojanguren, M A Bajo Rubio, A Cirugeda García, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
September 18, 1998
Recombinant human growth hormone therapy in malnourished dialysis patients: a randomized controlled study
P Iglesias, J J Díez, M J Fernández-Reyes, et al.
Medicina Clinica
|
October 19, 1985
[Pancreatic beta cell function in patients treated with continuous ambulatory peritoneal dialysis. Its evolution in time and its relation with metabolic complications]
R Selgas, R Albero, J Muñoz, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|
March 1, 1997
Erythropoietin treatment decreases cardiovascular morbidity and mortality in CAPD patients
M A Bajo, R Selgas, M J Castro, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 182) with videos related to
Sort By:
Page
of 19
Medicina Clinica
|
September 25, 1981
[Comparative biochemical study of serum and residual peritoneal fluid in periodic peritoneal maintenance dialysis (author's transl)]
R Selgas Gutiérrez, D Lorenzo Aguiar, M Rivero Sánchez, et al.
Contributions to Nephrology
|
January 1, 1987
Peritoneal membrane failure as a determinant of the CAPD future. An epidemiological, functional and pathological study
E Huarte-Loza, R Selgas, A R Carmona, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia
|
October 30, 2008
Apoptosis: from advances in PD to therapeutic targets in DM
B Santamaría, A B Sanz, A C Ucero, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia
|
August 5, 2000
[Methods to assess the ex vivo growth capacity of mesothelial cells obtained directly from peritoneal effluent]
M A Castro, C Díaz, M A Bajo, et al.
Journal of Nephrology
|
August 17, 2001
Vascular endothelial growth factor (VEGF) levels in peritoneal dialysis effluent
R Selgas, G del Peso, M A Bajo, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis
|
January 1, 1993
Peritoneal resting is beneficial in peritoneal hyperpermeability and ultrafiltration failure
F de Alvaro, M J Castro, F Dapena, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia
|
January 26, 2010
[Ten-year experience in intensive theoretical-practical course of ongoing training in peritoneal dialysis]
C Hevia Ojanguren, M A Bajo Rubio, A Cirugeda García, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
September 18, 1998
Recombinant human growth hormone therapy in malnourished dialysis patients: a randomized controlled study
P Iglesias, J J Díez, M J Fernández-Reyes, et al.
Medicina Clinica
|
October 19, 1985
[Pancreatic beta cell function in patients treated with continuous ambulatory peritoneal dialysis. Its evolution in time and its relation with metabolic complications]
R Selgas, R Albero, J Muñoz, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|
March 1, 1997
Erythropoietin treatment decreases cardiovascular morbidity and mortality in CAPD patients
M A Bajo, R Selgas, M J Castro, et al.
Page
of 19